You are here: Industry Insights > COVID-19

News List

BioMed X Launches Rapid Antiviral Response Platform contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.
Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact contractpharma
May 14, 2020
Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19.
Acer Therapeutics, NCATS partner to develop emetine for Covid-19 pharmaceutical-technology
May 14, 2020
Pharmaceutical company Acer Therapeutics has partnered with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride for the potential treatment of Covid-19 patients.
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan fo expresspharma
May 14, 2020
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process for remdesivir to enable them to scale up production more quickly.
HP University scientists gets Microsoft Grant for coronavirus research expresspharma
May 14, 2020
The team will perform screening of phytochemical constituents for anti-viral activity through interaction with COVID-19 specific targets using molecular modelling studies.
Study reveals novel coronavirus may infect human intestines expresspharma
May 14, 2020
Researchers were able to isolate SARS-CoV-2 from the stool specimen of a female patient diagnosed with COVID-19, which suggests that intestinal infection may have occurred.
NIHR, UKRI call for new COVID-19 research proposals pharmatimes
May 13, 2020
The NIHR and UK Research and Innovation (UKRI) are calling for new research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2.
Ultromics, Mayo Clinic Collaborate to Rapidly Assess COVID-19 Patients Using AI americanpharmaceuticalreview
May 13, 2020
A joint UK-US research team is applying an artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.
Viracor Eurofins Launches Antibody Tests for SARS-CoV-2 americanpharmaceuticalreview
May 13, 2020
Viracor Eurofins announced the launch of its antibody assays for Coronavirus (COVID-19) SARS-CoV-2.
Junshi, Lilly to Co-develop Antibody Therapies for COVID-19 contractpharma
May 13, 2020
Multiple neutralizing antibodies have been engineered, with the lead asset poised to enter clinical testing in the second quarter.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page